Skip to content

Clinical trials

Phase 4 Carcinoma, Hepatocellular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 4 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20141
20151
20182
20201
20211
20233
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor Research Institute1
Fox Chase Cancer Center1
Guerbet1
Icahn School of Medicine at Mount Sinai1
Lisa Sanderson Cox, PhD1
Milton S. Hershey Medical Center1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Nguyen Thi Trieu, MD1
OHSU Knight Cancer Institute1
Philipp Dutkowski1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular15
Liver Neoplasms7
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Renal Cell3
Lung Neoplasms3
Esophageal Neoplasms2
Fibrosis2
Head and Neck Neoplasms2
Hypopharyngeal Neoplasms2
Kidney Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.